Table 4.
Treatment |
Increase in skin thickness (%) to PHA and DNCB
|
|
Relative lymphoid organ weights (g per 100 g body weight)
|
||
---|---|---|---|---|---|
PHA | DNCB | Bursa | Spleen | ||
PE1 | 0.65 | 1.81bc | 0.09 | 0.09 | |
PE2 | 0.55 | 1.75bc | 0.10 | 0.08 | |
PO1 | 0.64 | 2.32ab | 0.09 | 0.09 | |
PO2 | 0.83 | 2.46ab | 0.10 | 0.08 | |
RJ | 0.30 | 1.53c | 0.14 | 0.09 | |
V | 0.94 | 2.26abc | 0.12 | 0.08 | |
H | 0.76 | 2.67a | 0.10 | 0.06 | |
C
|
0.74 |
1.55c |
|
0.11 |
0.07 |
SEM
|
0.0629 |
0.0884 |
|
0.0046 |
0.0032 |
p -value | 0.3282 | 0.0001 | 0.2307 | 0.1231 |
PE1: 1000 and PE2: 5000 mg kg-1 ethanolic extract of propolis, PO1: 1000 and PO2: 5000 mg kg-1 pollen powder, RJ: 100 mg kg-1 royal jelly, H: honey 22 g L-1, C: control and V: virginiamycin 150 mg kg-1. SEM: Standard error of mean.
different superscripts indicate statistically differences in each column (p < 0.05).